Retrospective Study
Copyright ©The Author(s) 2015.
World J Transplant. Sep 24, 2015; 5(3): 102-109
Published online Sep 24, 2015. doi: 10.5500/wjt.v5.i3.102
Figure 1
Figure 1 Trends in the use of induction agents stratified by peak-panel reactive antibody in steroid maintenance (A) and early steroid withdrawal (B) groups. Alemtuzumab is used more commonly in steroid withdrawal group. r-ATG: Rabbit- antithymocyte globulin; PRA: Panel reactive antibody.